Financhill
Buy
73

FJTSY Quote, Financials, Valuation and Earnings

Last price:
$17.78
Seasonality move :
-0.62%
Day range:
$17.86 - $18.47
52-week range:
$13.08 - $22.01
Dividend yield:
0.98%
P/E ratio:
18.79x
P/S ratio:
1.32x
P/B ratio:
2.72x
Volume:
139.8K
Avg. volume:
160.1K
1-year change:
26.81%
Market cap:
$32.9B
Revenue:
$26B
EPS (TTM):
$0.96
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Revenue $35.5B $33.9B $32B $27.5B $26B
Revenue Growth (YoY) -0.44% -4.6% -5.65% -13.92% -5.36%
 
Cost of Revenues $25.3B $23.7B $22B $19B $18B
Gross Profit $10.2B $10.2B $10B $8.5B $8.1B
Gross Profit Margin 28.76% 30.09% 31.19% 30.81% 31.01%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $8B $7.9B $7.6B $6.3B $6.3B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $8.3B $7.7B $8B $6B $7B
Operating Income $1.9B $2.5B $2B $2.5B $1.1B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $2.1B $2.8B $2.1B $2.8B $1.2B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $627.8M $738.9M $239.1M $940.6M -$613.3M
Net Income to Company $2.1B $2.8B $2.1B $2.8B $1.2B
 
Minority Interest in Earnings -$2.6M -$102.1M -$271.2M -$219.8M -$84.6M
Net Income to Common Excl Extra Items $1.5B $1.9B $1.6B $1.6B $1.8B
 
Basic EPS (Cont. Ops) $0.73 $0.96 $0.82 $0.82 $0.94
Diluted EPS (Cont. Ops) $0.73 $0.96 $0.82 $0.82 $0.94
Weighted Average Basic Share $2B $2B $2B $1.9B $1.9B
Weighted Average Diluted Share $2B $2B $2B $1.9B $1.9B
 
EBITDA $4.1B $4.4B $3.8B $4.1B $2.6B
EBIT $2.1B $2.8B $2.2B $2.8B $1.3B
 
Revenue (Reported) $35.5B $33.9B $32B $27.5B $26B
Operating Income (Reported) $1.9B $2.5B $2B $2.5B $1.1B
Operating Income (Adjusted) $2.1B $2.8B $2.2B $2.8B $1.3B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $7.5B $7.3B $6.3B $5.8B $5.3B
Revenue Growth (YoY) -2.24% -1.79% -13.75% -7.79% -8.63%
 
Cost of Revenues $5.4B $5.1B $4.5B $4.2B $3.8B
Gross Profit $2.1B $2.2B $1.8B $1.6B $1.6B
Gross Profit Margin 27.89% 30.67% 29.08% 27.72% 29.3%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.9B $2B $1.6B $1.6B $1.4B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.9B $1.9B $1.6B $1.6B $1.4B
Operating Income $207M $308.2M $197.6M -$12.1M $137.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $241.2M $361.7M $295.9M $62.5M $169.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $63.2M $91.9M $84.9M $17M $43.8M
Net Income to Company $241.2M $361.7M $295.9M $62.5M --
 
Minority Interest in Earnings -$9.1M -$49.1M -$77.6M -$13.7M -$17.6M
Net Income to Common Excl Extra Items $168.9M $220.8M $133.4M $31.7M $108.3M
 
Basic EPS (Cont. Ops) $0.08 $0.11 $0.07 $0.02 $0.06
Diluted EPS (Cont. Ops) $0.08 $0.11 $0.07 $0.02 $0.06
Weighted Average Basic Share $2B $2B $2B $1.9B $1.8B
Weighted Average Diluted Share $2B $2B $2B $1.9B $1.8B
 
EBITDA $630.4M $773.6M $648.9M $358.1M $438.1M
EBIT $251.3M $368.9M $304.1M $71.3M $188.8M
 
Revenue (Reported) $7.5B $7.3B $6.3B $5.8B $5.3B
Operating Income (Reported) $207M $308.2M $197.6M -$12.1M $137.2M
Operating Income (Adjusted) $251.3M $368.9M $304.1M $71.3M $188.8M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $35.3B $33.7B $30.9B $27B $25.4B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $25.1B $23.4B $21.3B $18.8B $17.5B
Gross Profit $10.2B $10.4B $9.5B $8.3B $8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.9B $7.9B $7.3B $6.3B $6.1B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $8.1B $7.7B $7.7B $6B $6.7B
Operating Income $2.1B $2.6B $1.8B $2.3B $1.2B
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $2.3B $2.9B $2.1B $2.5B $1.3B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $686.2M $770.4M $233.2M $873.5M -$565.3M
Net Income to Company $2.3B $2.9B $2.1B $2.5B --
 
Minority Interest in Earnings -$25.7M -$142.5M -$299.3M -$155.8M -$88M
Net Income to Common Excl Extra Items $1.6B $2B $1.5B $1.5B $1.8B
 
Basic EPS (Cont. Ops) $0.78 $0.99 $0.77 $0.77 $0.96
Diluted EPS (Cont. Ops) $0.78 $0.99 $0.77 $0.77 $0.96
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $4.2B $4.6B $3.7B $3.9B $2.6B
EBIT $2.3B $2.9B $2.1B $2.6B $1.4B
 
Revenue (Reported) $35.3B $33.7B $30.9B $27B $25.4B
Operating Income (Reported) $2.1B $2.6B $1.8B $2.3B $1.2B
Operating Income (Adjusted) $2.3B $2.9B $2.1B $2.6B $1.4B
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue $7.5B $7.3B $6.3B $5.8B $5.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $5.4B $5.1B $4.5B $4.2B $3.8B
Gross Profit $2.1B $2.2B $1.8B $1.6B $1.6B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.9B $2B $1.6B $1.6B $1.4B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.9B $1.9B $1.6B $1.6B $1.4B
Operating Income $207M $308.2M $197.6M -$12.1M $137.2M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $241.2M $361.7M $295.9M $62.5M $169.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $63.2M $91.9M $84.9M $17M $43.8M
Net Income to Company $241.2M $361.7M $295.9M $62.5M --
 
Minority Interest in Earnings -$9.1M -$49.1M -$77.6M -$13.7M -$17.6M
Net Income to Common Excl Extra Items $168.9M $220.8M $133.4M $31.7M $108.3M
 
Basic EPS (Cont. Ops) $0.08 $0.11 $0.07 $0.02 $0.06
Diluted EPS (Cont. Ops) $0.08 $0.11 $0.07 $0.02 $0.06
Weighted Average Basic Share $2B $2B $2B $1.9B $1.8B
Weighted Average Diluted Share $2B $2B $2B $1.9B $1.8B
 
EBITDA $630.4M $773.6M $648.9M $358.1M $438.1M
EBIT $251.3M $368.9M $304.1M $71.3M $188.8M
 
Revenue (Reported) $7.5B $7.3B $6.3B $5.8B $5.3B
Operating Income (Reported) $207M $308.2M $197.6M -$12.1M $137.2M
Operating Income (Adjusted) $251.3M $368.9M $304.1M $71.3M $188.8M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Cash and Equivalents $4.2B $4.4B $4B $2.7B $2.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $8.1B $7.8B $7.2B $7B $6.1B
Inventory $2.2B $2.1B $2.5B $2.5B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2B $1.2B $744.1M $651.9M $655.3M
Total Current Assets $17.5B $17B $15.9B $14.4B $12.5B
 
Property Plant And Equipment $5.3B $5.2B $4.7B $4.3B $4B
Long-Term Investments -- -- -- -- --
Goodwill $339.7M $373.8M $389.1M $413.8M $529.9M
Other Intangibles $992M $1.1B $1.1B $1.1B $1.4B
Other Long-Term Assets $1.8B $608.1M $506.8M $509.9M $587.2M
Total Assets $29.5B $28.9B $27.3B $24.5B $23.2B
 
Accounts Payable $4.4B $4.2B $3.9B $3.5B $3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.8B $291.7M $274.2M $204.1M $206M
Total Current Liabilities $12.6B $11.7B $10.8B $9.6B $8.7B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $17B $14.9B $13.2B $11.5B $10.5B
 
Common Stock $3B $2.9B $2.7B $2.4B $2.2B
Other Common Equity Adj -- -- -- -- --
Common Equity $11.5B $13.1B $13B $11.9B $11.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $994.5M $877.2M $1B $1.1B $1.1B
Total Equity $12.5B $14B $14.1B $13B $12.7B
 
Total Liabilities and Equity $29.5B $28.9B $27.3B $24.5B $23.2B
Cash and Short Terms $4.2B $4.4B $4B $2.7B $2.3B
Total Debt $3.8B $2.9B $2.3B $1.6B $1.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $4.6B $4.3B $3.2B $2.4B $2.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $5.4B $5B $4.1B $4.1B $4B
Inventory $2.5B $2.7B $2.7B $2.5B $2.5B
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.8B $3B $700.7M $1.1B $844M
Total Current Assets $16.4B $15.4B $12.8B $12.3B $12.2B
 
Property Plant And Equipment $5.3B $5.2B $3.9B $4B $4.2B
Long-Term Investments -- -- -- -- --
Goodwill $368.8M $370.7M $381.2M $665.7M $544.8M
Other Intangibles $1.1B $1.1B $935.7M $1.1B $1.6B
Other Long-Term Assets $1.5B $1.6B $401.2M $488.5M $635.6M
Total Assets $28.3B $27.3B $22.3B $21.8B $23.7B
 
Accounts Payable $3.9B $3.8B $3B $2.7B $2.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.9B $1.8B $215.6M $194.8M $218.2M
Total Current Liabilities $11.7B $10.3B $8.1B $8B $8.5B
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $15.5B $13.1B $9.9B $9.6B $10.4B
 
Common Stock $3.1B $2.9B $2.2B $2.2B $2.3B
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $833.4M $974.9M $990.4M $1.1B $1.2B
Total Equity $12.8B $14.1B $12.4B $12.2B $13.3B
 
Total Liabilities and Equity $28.3B $27.3B $22.3B $21.8B $23.7B
Cash and Short Terms $4.6B $4.3B $3.2B $2.4B $2.5B
Total Debt $3.5B $2.6B $1.7B $1.5B --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $2.1B $2.8B $2.1B $2.8B $1.2B
Depreciation & Amoritzation $2B $1.7B $1.7B $1.3B $1.3B
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $100M $206.8M -$189.9M -$548.1M $42.4M
Change in Inventories -$175.5M $33.1M -$616.4M -$384.6M $307.4M
Cash From Operations $3.2B $2.9B $2.2B $1.6B $2.1B
 
Capital Expenditures $1.2B $1.2B $1.3B $1.2B $1.4B
Cash Acquisitions $372.8M $403.2M $93.2M $579.3M -$504.8M
Cash From Investing -$1.1B -$675.1M -$527.9M -$317M -$1.1B
 
Dividends Paid (Ex Special Dividend) -$298.4M -$377.8M -$371.3M -$334.8M -$326.4M
Special Dividend Paid
Long-Term Debt Issued $27.6K $5.1M $1.2M $16.8M $2M
Long-Term Debt Repaid -$738.4M -$758.2M -$475.9M -$261.4M -$14.7M
Repurchase of Common Stock -$277M -$190M -$446.8M -$1.1B -$715M
Other Financing Activities $6.4M -$182.5M -$16.9M -$8.7M -$42.3M
Cash From Financing -$1.8B -$2.1B -$1.7B -$2.3B -$1.3B
 
Beginning Cash (CF) $3.8B $4.3B $4.3B $3.6B $2.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $367M $158.1M -$41M -$1B -$204.5M
Ending Cash (CF) $4.2B $4.5B $4.3B $2.6B $2.4B
 
Levered Free Cash Flow $2B $1.7B $936.2M $386.8M $785.7M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders $865.2M $1.2B $744.1M $1.3B $821.8M
Depreciation & Amoritzation $501.8M $458.6M $477.2M $403.1M $428.3M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$2.5B -$2.9B -$1.9B -$1.3B -$1.3B
Change in Inventories $845M $440.8M $254.3M $463.1M $557.5M
Cash From Operations $1.2B $995.4M $501.7M $1.1B $1.1B
 
Capital Expenditures $313.2M $333M $337.9M $424.2M $391.4M
Cash Acquisitions $2.8M $4.1M -$35.4M $73.6M -$232.5M
Cash From Investing -$641.3M -$280M $220.2M -$123.6M -$524.4M
 
Dividends Paid (Ex Special Dividend) -$142.1K $5.7M -$4.6M -$14.1M -$7.4M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $10 $708K $604.3K $7.7M $147.4K
Long-Term Debt Repaid -$368.9M -$229.9M -$9.1M -$118.9M -$4.6M
Repurchase of Common Stock -$276.3M -$189.1M -$78.6M -$614.7M -$714.4M
Other Financing Activities $7.3M -$69.1M -$33.9M $2.3M $2.3M
Cash From Financing -$1B -$665.4M -$271.9M -$1.1B -$786.7M
 
Beginning Cash (CF) $4.6B $4.5B $3.8B $2.6B $2.5B
Foreign Exchange Rate Adjustment -$29.7M $68.7M $46.1M $22.1M $51.6M
Additions / Reductions -$449.5M $50.1M $450M -$153.1M -$204.4M
Ending Cash (CF) $4.2B $4.5B $4.3B $2.6B $2.4B
 
Levered Free Cash Flow $888.4M $662.4M $163.8M $661.7M $715.3M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders $2.3B $2.9B $2.1B $2.5B --
Depreciation & Amoritzation $1.8B $1.7B $1.6B $1.3B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $254M -$50.9M -$967.3M -$227M --
Change in Inventories $216M -$191M -$818.4M -$182.5M --
Cash From Operations $3.5B $3.3B $1.4B $1.9B $2B
 
Capital Expenditures $1.2B $1.3B $1.3B $1.2B $1.1B
Cash Acquisitions $467.3M $379.1M $29.4M $313.1M -$239.3M
Cash From Investing -$1B -$847.2M -$714M -$176.2M --
 
Dividends Paid (Ex Special Dividend) -$336.9M -$373.5M -$356.3M -$332.7M -$161.7M
Special Dividend Paid
Long-Term Debt Issued $1.2M $4.5M -- -- --
Long-Term Debt Repaid -$374.3M -$1B -- -- --
Repurchase of Common Stock -$277M -$282.1M -$354.8M -$1.1B --
Other Financing Activities $5.9M -$177M -$31M -$22M --
Cash From Financing -$1.5B -$2.5B -$1.6B -$2B --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $979.5M -$52.4M -$918.7M -$253.9M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.3B $2B $123.3M $728M --
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $2.8B $2.1B $2.8B $1.2B --
Depreciation & Amoritzation $1.7B $1.7B $1.3B $1.3B --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $206.8M -$189.9M -$548.1M $42.4M --
Change in Inventories $33.1M -$616.4M -$384.6M $307.4M --
Cash From Operations $2.9B $2.2B $1.6B $2.1B --
 
Capital Expenditures $1.2B $1.3B $1.2B $1.4B --
Cash Acquisitions $403.2M $93.2M $579.3M -$504.8M --
Cash From Investing -$675.1M -$527.9M -$317M -$1.1B --
 
Dividends Paid (Ex Special Dividend) -$377.8M -$371.3M -$334.8M -$326.4M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $5.1M $1.2M $16.8M $2M --
Long-Term Debt Repaid -$758.2M -$475.9M -$261.4M -$14.7M --
Repurchase of Common Stock -$190M -$446.8M -$1.1B -$715M --
Other Financing Activities -$182.5M -$16.9M -$8.7M -$42.3M --
Cash From Financing -$2.1B -$1.7B -$2.3B -$1.3B --
 
Beginning Cash (CF) $18.6B $17.8B $13.4B $11B --
Foreign Exchange Rate Adjustment $113.5M $60.5M $58.8M $109.1M --
Additions / Reductions $158.1M -$41M -$1B -$204.5M --
Ending Cash (CF) $19B $17.7B $12.3B $10.7B --
 
Levered Free Cash Flow $1.7B $936.2M $386.8M $785.7M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.8% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.65% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 4.96% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock